CIM
Contrarius Investment Management’s Myriad Genetics MYGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-248,090
| Closed | -$7.33M | – | 66 |
|
|
2018
Q1 | $7.33M | Buy |
248,090
+12,355
| +5% | +$365K | 0.35% | 39 |
|
|
2017
Q4 | $8.1M | Sell |
235,735
-72,328
| -23% | -$2.48M | 0.4% | 36 |
|
|
2017
Q3 | $11.1M | Sell |
308,063
-25,716
| -8% | -$930K | 0.65% | 36 |
|
|
2017
Q2 | $8.63M | Sell |
333,779
-182,142
| -35% | -$4.71M | 0.58% | 30 |
|
|
2017
Q1 | $9.91M | Buy |
515,921
+113,486
| +28% | +$2.18M | 0.64% | 29 |
|
|
2016
Q4 | $6.71M | Buy |
402,435
+134,664
| +50% | +$2.24M | 0.5% | 27 |
|
|
2016
Q3 | $5.51M | Buy |
267,771
+177,263
| +196% | +$3.65M | 0.41% | 38 |
|
|
2016
Q2 | $2.77M | Sell |
90,508
-493,696
| -85% | -$15.1M | 0.24% | 45 |
|
|
2016
Q1 | $21.9M | Sell |
584,204
-68,084
| -10% | -$2.55M | 1.94% | 15 |
|
|
2015
Q4 | $28.2M | Sell |
652,288
-95,573
| -13% | -$4.12M | 2.65% | 12 |
|
|
2015
Q3 | $28M | Sell |
747,861
-29,972
| -4% | -$1.12M | 2.77% | 12 |
|
|
2015
Q2 | $26.4M | Buy |
777,833
+245,900
| +46% | +$8.36M | 2.06% | 18 |
|
|
2015
Q1 | $18.8M | Buy |
+531,933
| New | +$18.8M | 1.51% | 19 |
|